Form 4: Ionis Pharmaceuticals Officer Richard S. Geary Reports Stock Purchase

Sentiment:

SEC Form 4 Filing


Richard S. Geary, an officer at Ionis Pharmaceuticals, reports purchasing 604 shares of common stock at $34.425 per share through the company's employee stock purchase plan.

Summary

  • On February 29, 2024, Richard S. Geary, an officer at Ionis Pharmaceuticals, acquired 604 shares of common stock.
  • The purchase was made through the Ionis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan.
  • The price per share was $34.425.
  • Following the transaction, Geary directly owns 87,938 shares of Ionis Pharmaceuticals common stock.
  • These shares may not be sold until August 31, 2024.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of an officer's stock purchase. It doesn't inherently indicate positive or negative news about the company.

Positives

  • The purchase of shares by an officer could be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This is a routine disclosure related to insider trading. It is common for company officers to participate in employee stock purchase plans.

Stakeholder Impact

  • The stock purchase could have a minor positive impact on shareholder sentiment.

Key Dates

DateDescription
02/29/2024Date of stock purchase transaction
03/04/2024Date of Form 4 filing
08/31/2024Date when the purchased shares can be sold

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.